{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:47:09Z","timestamp":1780361229393,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170188"],"award-info":[{"award-number":["82170188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170188"],"award-info":[{"award-number":["82170188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170188"],"award-info":[{"award-number":["82170188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170188"],"award-info":[{"award-number":["82170188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170188"],"award-info":[{"award-number":["82170188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170188"],"award-info":[{"award-number":["82170188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170188"],"award-info":[{"award-number":["82170188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170188"],"award-info":[{"award-number":["82170188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170188"],"award-info":[{"award-number":["82170188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170188"],"award-info":[{"award-number":["82170188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170188"],"award-info":[{"award-number":["82170188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00277-025-06243-y","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T19:54:26Z","timestamp":1739303666000},"page":"1069-1078","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Metabolic parameter of baseline 18\u00a0F-FDG PET\/CT with PINK models improve the prediction of treatment outcome in extranodal NK\/T-cell lymphoma treated with P-GEMOX chemotherapy"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1358-6293","authenticated-orcid":false,"given":"Cheng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7363-4387","authenticated-orcid":false,"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4614-6892","authenticated-orcid":false,"given":"Haixia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6829-5955","authenticated-orcid":false,"given":"Yan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8937-9042","authenticated-orcid":false,"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3708-7640","authenticated-orcid":false,"given":"Bing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2556-7834","authenticated-orcid":false,"given":"Liqin","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6389-6903","authenticated-orcid":false,"given":"Yanxia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoumin","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0568-263X","authenticated-orcid":false,"given":"Xiaoxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4623-0536","authenticated-orcid":false,"given":"Huiqiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"issue":"1","key":"6243_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13045-019-0717-6","volume":"12","author":"N Somasundaram","year":"2019","unstructured":"Somasundaram N, Lim JQ, Ong CK, Lim ST (2019) Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL). J Hematol Oncol 12(1):28. https:\/\/doi.org\/10.1186\/s13045-019-0717-6","journal-title":"J Hematol Oncol"},{"issue":"9","key":"6243_CR2","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1038\/s41375-021-01313-2","volume":"35","author":"H Wang","year":"2021","unstructured":"Wang H, Fu BB, Gale RP, Liang Y (2021) NK-\/T-cell lymphomas. Leukemia 35(9):2460\u20132468. https:\/\/doi.org\/10.1038\/s41375-021-01313-2","journal-title":"Leukemia"},{"issue":"9","key":"6243_CR3","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1200\/jco.2015.63.5540","volume":"34","author":"SV Adams","year":"2016","unstructured":"Adams SV, Newcomb PA, Shustov AR (2016) Racial patterns of peripheral T-Cell lymphoma incidence and survival in the United States. J Clin Oncol 34(9):963\u2013971. https:\/\/doi.org\/10.1200\/jco.2015.63.5540","journal-title":"J Clin Oncol"},{"issue":"4","key":"6243_CR4","doi-asserted-by":"publisher","first-page":"e284","DOI":"10.1016\/S2352-3026(19)30283-2","volume":"7","author":"CP Fox","year":"2020","unstructured":"Fox CP, Civallero M, Ko YH, Manni M, Skrypets T, Pileri S, Kim SJ, Cabrera ME, Shustov AR, Chiattone CS, Horwitz SM, Dlouhy I, Spina M, Hitz F, Montoto S, Nagler A, Martinez V, De Souza CA, Fernandez-Alvarez R, Ballova V, Gabus R, Inghirami G, Federico M, Kim WS (2020) Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell project. Lancet Haematol 7(4):e284\u2013e294. https:\/\/doi.org\/10.1016\/S2352-3026(19)30283-2","journal-title":"Lancet Haematol"},{"issue":"23","key":"6243_CR5","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1182\/blood-2017-12-791418","volume":"131","author":"M Yamaguchi","year":"2018","unstructured":"Yamaguchi M, Suzuki R, Oguchi M (2018) Advances in the treatment of extranodal NK\/T-cell lymphoma, nasal type. Blood 131(23):2528\u20132540. https:\/\/doi.org\/10.1182\/blood-2017-12-791418","journal-title":"Blood"},{"issue":"13","key":"6243_CR6","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1182\/bloodadvances.2020001852","volume":"4","author":"SN Qi","year":"2020","unstructured":"Qi SN, Yang Y, Song YQ, Wang Y, He X, Hu C, Zhang LL, Wu G, Qu BL, Qian LT, Hou XR, Zhang FQ, Qiao XY, Wang H, Li GF, Huang HQ, Zhang YJ, Zhu Y, Cao JZ, Wu JX, Wu T, Zhu SY, Shi M, Xu LM, Yuan ZY, Su H, Zhu J, Li YX (2020) First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK\/T-cell lymphoma: a retrospective analysis from the CLCG. Blood Adv 4(13):3141\u20133153. https:\/\/doi.org\/10.1182\/bloodadvances.2020001852","journal-title":"Blood Adv"},{"issue":"6","key":"6243_CR7","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1182\/blood-2010-09-307454","volume":"117","author":"A Jaccard","year":"2011","unstructured":"Jaccard A, Gachard N, Marin B, Rogez S, Audrain M, Suarez F, Tilly H, Morschhauser F, Thieblemont C, Ysebaert L, Devidas A, Petit B, de Leval L, Gaulard P, Feuillard J, Bordessoule D, Hermine O, Gela, Intergroup G (2011) Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK\/T-cell lymphoma, a phase 2 study. Blood 117(6):1834\u20131839. https:\/\/doi.org\/10.1182\/blood-2010-09-307454","journal-title":"Blood"},{"issue":"33","key":"6243_CR8","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","volume":"29","author":"M Yamaguchi","year":"2011","unstructured":"Yamaguchi M, Kwong YL, Kim WS, Maeda Y, Hashimoto C, Suh C, Izutsu K, Ishida F, Isobe Y, Sueoka E, Suzumiya J, Kodama T, Kimura H, Hyo R, Nakamura S, Oshimi K, Suzuki R (2011) Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncology: Official J Am Soc Clin Oncol 29(33):4410\u20134416. https:\/\/doi.org\/10.1200\/JCO.2011.35.6287","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"2","key":"6243_CR9","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3892\/ol.2015.3327","volume":"10","author":"L Wang","year":"2015","unstructured":"Wang L, Wang ZH, Chen XQ, Wang KF, Huang HQ, Xia ZJ (2015) First-line combination of GELOX followed by radiation therapy for patients with stage IE\/IIE ENKTL: an updated analysis with long-term follow-up. Oncol Lett 10(2):1036\u20131040. https:\/\/doi.org\/10.3892\/ol.2015.3327","journal-title":"Oncol Lett"},{"issue":"Supplement1","key":"6243_CR10","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1182\/blood-2019-123478","volume":"134","author":"H-q Huang","year":"2019","unstructured":"Huang H-q, Yan G, Su H, Huang Y, Gao Y, Xiaoxiao W, Bing B, Zhang Y, Su L, Chu X, Li W, Zhang J, Zhang Q, Zhang L, Hu X, Zou L, Li Z, Jiang W (2019) Clinical outcome of an multicentre, randomized, phase II clinical trial for patients with Extranodal NK\/T cell lymphoma treated by P-Gemox or Aspametdex. Blood 134(Supplement1):1569\u20131569. https:\/\/doi.org\/10.1182\/blood-2019-123478","journal-title":"Blood"},{"issue":"11","key":"6243_CR11","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1002\/ajh.26335","volume":"96","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Ma S, Cai J, Yang Y, Jing H, Shuang Y, Peng Z, Li B, Liu P, Xia Z, Xia Y, Gao Y, Chen D, Lin J, Li Q, Xu S, Xu Q, Zhang H, Huang H, Cai Q (2021) Sequential P-GEMOX and radiotherapy for early-stage extranodal natural killer\/T-cell lymphoma: a multicenter study. Am J Hematol 96(11):1481\u20131490. https:\/\/doi.org\/10.1002\/ajh.26335","journal-title":"Am J Hematol"},{"issue":"9","key":"6243_CR12","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1093\/annonc\/mdx316","volume":"28","author":"SH Lim","year":"2017","unstructured":"Lim SH, Hong JY, Lim ST, Hong H, Arnoud J, Zhao W, Yoon DH, Tang T, Cho J, Park S, Ko YH, Kim SJ, Suh C, Lin T, Kim WS (2017) Beyond first-line non-anthracycline-based chemotherapy for extranodal NK\/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease. Ann Oncol 28(9):2199\u20132205. https:\/\/doi.org\/10.1093\/annonc\/mdx316","journal-title":"Ann Oncol"},{"key":"6243_CR13","doi-asserted-by":"crossref","unstructured":"Project IN-HLPF (1993) A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med 329(14):987\u2013994","DOI":"10.1056\/NEJM199309303291402"},{"issue":"4","key":"6243_CR14","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1200\/jco.2005.04.1384","volume":"24","author":"J Lee","year":"2006","unstructured":"Lee J, Suh C, Park YH, Ko YH, Bang SM, Lee JH, Lee DH, Huh J, Oh SY, Kwon H-C, Kim HJ, Lee SI, Kim JH, Park J, Oh SJ, Kim K, Jung C, Park K, Kim WS (2006) Extranodal natural killer T-Cell lymphoma, Nasal-Type: a prognostic model from a retrospective multicenter study. J Clin Oncol 24(4):612\u2013618. https:\/\/doi.org\/10.1200\/jco.2005.04.1384","journal-title":"J Clin Oncol"},{"issue":"3","key":"6243_CR15","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/s1470-2045(15)00533-1","volume":"17","author":"SJ Kim","year":"2016","unstructured":"Kim SJ, Yoon DH, Jaccard A, Chng WJ, Lim ST, Hong H, Park Y, Chang KM, Maeda Y, Ishida F, Shin D-Y, Kim JS, Jeong SH, Yang D-H, Jo J-C, Lee G-W, Choi CW, Lee W-S, Chen T-Y, Kim K, Jung S-H, Murayama T, Oki Y, Advani R, d\u2019Amore F, Schmitz N, Suh C, Suzuki R, Kwong YL, Lin T-Y, Kim WS (2016) A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncol 17(3):389\u2013400. https:\/\/doi.org\/10.1016\/s1470-2045(15)00533-1","journal-title":"Lancet Oncol"},{"issue":"1","key":"6243_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1200\/jco.2016.68.1619","volume":"35","author":"M Yamaguchi","year":"2017","unstructured":"Yamaguchi M, Suzuki R, Oguchi M, Asano N, Amaki J, Akiba T, Maeda T, Itasaka S, Kubota N, Saito Y, Kobayashi Y, Itami J, Ueda K, Miyazaki K, Ii N, Tomita N, Sekiguchi N, Takizawa J, Saito B, Murayama T, Ando T, Wada H, Hyo R, Ejima Y, Hasegawa M, Katayama N (2017) Treatments and outcomes of patients with extranodal natural killer\/T-Cell lymphoma diagnosed between 2000 and 2013: a cooperative study in Japan. J Clin Oncol: OffJ Am Soc Clin Oncol 35(1):32\u201339. https:\/\/doi.org\/10.1200\/jco.2016.68.1619","journal-title":"J Clin Oncol: OffJ Am Soc Clin Oncol"},{"issue":"7","key":"6243_CR17","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1038\/leu.2015.44","volume":"29","author":"Y Yang","year":"2015","unstructured":"Yang Y, Zhang YJ, Zhu Y, Cao JZ, Yuan ZY, Xu LM, Wu JX, Wang W, Wu T, Lu B, Zhu SY, Qian LT, Zhang FQ, Hou XR, Liu QF, Li YX (2015) Prognostic nomogram for overall survival in previously untreated patients with extranodal NK\/T-cell lymphoma, nasal-type: a multicenter study. Leukemia 29(7):1571\u20131577. https:\/\/doi.org\/10.1038\/leu.2015.44","journal-title":"Leukemia"},{"issue":"1","key":"6243_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41375-020-0791-3","volume":"35","author":"SY Chen","year":"2021","unstructured":"Chen SY, Yang Y, Qi SN, Wang Y, Hu C, He X, Zhang LL, Wu G, Qu BL, Qian LT, Hou XR, Zhang FQ, Qiao XY, Wang H, Li GF, Zhang YJ, Zhu Y, Cao JZ, Lan SM, Wu JX, Wu T, Zhu SY, Shi M, Xu LM, Yuan ZY, Yahalom J, Tsang R, Song YQ, Zhu J, Su H, Li YX (2021) Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK\/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making. Leukemia 35(1):130\u2013142. https:\/\/doi.org\/10.1038\/s41375-020-0791-3","journal-title":"Leukemia"},{"issue":"6","key":"6243_CR19","first-page":"245","volume":"13","author":"XHW Zhang","year":"2023","unstructured":"Zhang XHW, Qiu Y, Chen Z, Song L, Yang Q, Kang L (2023) 18F-FDG PET\/CT in extranodal natural killer\/T-cell lymphoma: a comprehensive evaluation method. Am J Nucl Med Mol Imaging 13(6):245\u2013258","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"3","key":"6243_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/rlu.0000000000002440","volume":"44","author":"C Qin","year":"2019","unstructured":"Qin C, Yang S, Sun X, Xia X, Li C, Lan X (2019) 18F-FDG PET\/CT for prognostic stratification of patients with extranodal Natural Killer\/T-Cell lymphoma. Clin Nucl Med 44(3):201\u2013208. https:\/\/doi.org\/10.1097\/rlu.0000000000002440","journal-title":"Clin Nucl Med"},{"key":"6243_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/srep41057","volume":"7","author":"Y Chang","year":"2017","unstructured":"Chang Y, Fu X, Sun Z, Xie X, Wang R, Li Z, Zhang X, Sheng G, Zhang M (2017) Utility of baseline, interim and end-of-treatment (18)F-FDG PET\/CT in extranodal natural killer\/T-cell lymphoma patients treated with L-asparaginase\/pegaspargase. Sci Rep 7. https:\/\/doi.org\/10.1038\/srep41057","journal-title":"Sci Rep"},{"issue":"3","key":"6243_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194435","volume":"13","author":"H Wang","year":"2018","unstructured":"Wang H, Shen G, Jiang C, Li L, Cui F, Tian R (2018) Prognostic value of baseline, interim and end-of-treatment 18F-FDG PET\/CT parameters in extranodal natural killer\/T-cell lymphoma: a meta-analysis. PLoS ONE 13(3). https:\/\/doi.org\/10.1371\/journal.pone.0194435","journal-title":"PLoS ONE"},{"issue":"10","key":"6243_CR23","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.1007\/s00330-020-06943-1","volume":"30","author":"H Wang","year":"2020","unstructured":"Wang H, Zhao S, Li L, Tian R (2020) Development and validation of an (18)F-FDG PET radiomic model for prognosis prediction in patients with nasal-type extranodal natural killer\/T cell lymphoma. Eur Radiol 30(10):5578\u20135587. https:\/\/doi.org\/10.1007\/s00330-020-06943-1","journal-title":"Eur Radiol"},{"issue":"1","key":"6243_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40644-020-00379-y","volume":"21","author":"H Li","year":"2021","unstructured":"Li H, Shao G, Zhang Y, Chen X, Du C, Wang K, Gao Z (2021) Nomograms based on SUVmax of (18)F-FDG PET\/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer\/T-cell lymphoma. Cancer Imaging 21(1):9. https:\/\/doi.org\/10.1186\/s40644-020-00379-y","journal-title":"Cancer Imaging"},{"issue":"3","key":"6243_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e25184","volume":"10","author":"YM Zhu","year":"2024","unstructured":"Zhu YM, Peng P, Liu X, Qi SN, Wang SL, Fang H, Song YW, Liu YP, Jin J, Li N, Lu NN, Jing H, Tang Y, Chen B, Zhang WW, Zhai YR, Yang Y, Liang B, Zheng R, Li YX (2024) Optimizing the prognostic capacity of baseline (18)F-FDG PET\/CT metabolic parameters in extranodal natural killer\/T-cell lymphoma by using relative and absolute thresholds. Heliyon 10(3). https:\/\/doi.org\/10.1016\/j.heliyon.2024.e25184","journal-title":"Heliyon"},{"issue":"2","key":"6243_CR26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, Verzijlbergen FJ, Barrington SF, Pike LC, Weber WA, Stroobants S, Delbeke D, Donohoe KJ, Holbrook S, Graham MM, Testanera G, Hoekstra OS, Zijlstra J, Visser E, Hoekstra CJ, Pruim J, Willemsen A, Arends B, Kotzerke J, Bockisch A, Beyer T, Chiti A, Krause BJ (2015) FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 42(2):328\u2013354. https:\/\/doi.org\/10.1007\/s00259-014-2961-x","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"6243_CR27","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s00259-013-2443-6","volume":"40","author":"CY Kim","year":"2013","unstructured":"Kim CY, Hong CM, Kim DH, Son SH, Jeong SY, Lee SW, Lee J, Ahn BC (2013) Prognostic value of whole-body metabolic tumour volume and total lesion glycolysis measured on \u00b9\u2078F-FDG PET\/CT in patients with extranodal NK\/T-cell lymphoma. Eur J Nucl Med Mol Imaging 40(9):1321\u20131329. https:\/\/doi.org\/10.1007\/s00259-013-2443-6","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6243_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10428194.2020.1783446","volume":"1\u20136","author":"R Guo","year":"2020","unstructured":"Guo R, Xu P, Xu H, Miao Y, Li B (2020) The predictive value of pre-treatment (18)F-FDG PET\/CT on treatment outcome in early-stage extranodal natural killer\/T-cell lymphoma. Leuk Lymphoma 1\u20136:1. https:\/\/doi.org\/10.1080\/10428194.2020.1783446","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"6243_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.amjoto.2017.10.009","volume":"39","author":"K Pak","year":"2018","unstructured":"Pak K, Kim BS, Kim K, Kim IJ, Jun S, Jeong YJ, Shim HK, Kim SD, Cho KS (2018) Prognostic significance of standardized uptake value on F18-FDG PET\/CT in patients with extranodal nasal type NK\/T cell lymphoma: a multicenter, retrospective analysis. Am J Otolaryngol 39(1):1\u20135. https:\/\/doi.org\/10.1016\/j.amjoto.2017.10.009","journal-title":"Am J Otolaryngol"},{"issue":"1","key":"6243_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2967\/jnumed.119.226407","volume":"61","author":"SH Yoo","year":"2020","unstructured":"Yoo SH, Kang SY, Cheon GJ, Oh DY, Bang YJ (2020) Predictive role of temporal changes in Intratumoral metabolic heterogeneity during palliative chemotherapy in patients with advanced pancreatic cancer: a prospective cohort study. J Nucl Med: off Publ, Soc Nuclear Med 61(1):33\u201339. https:\/\/doi.org\/10.2967\/jnumed.119.226407","journal-title":"J Nucl Med: off Publ, Soc Nuclear Med"},{"key":"6243_CR31","doi-asserted-by":"publisher","unstructured":"Wahl RL, Jacene H, Kasamon Y, Lodge MA (2009) From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 50 Suppl 1. (Suppl 1):122s\u2013150s. https:\/\/doi.org\/10.2967\/jnumed.108.057307","DOI":"10.2967\/jnumed.108.057307"},{"issue":"1","key":"6243_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2967\/jnumed.111.093443","volume":"53","author":"M Vanderhoek","year":"2012","unstructured":"Vanderhoek M, Perlman SB, Jeraj R (2012) Impact of the definition of peak standardized uptake value on quantification of treatment response. J Nucl Med: Off Publ Soc Nucl Med 53(1):4\u201311. https:\/\/doi.org\/10.2967\/jnumed.111.093443","journal-title":"J Nucl Med: Off Publ Soc Nucl Med"},{"key":"6243_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0791-3","author":"SY Chen","year":"2020","unstructured":"Chen SY, Yang Y, Qi SN, Wang Y, Hu C, He X, Zhang LL, Wu G, Qu BL, Qian LT, Hou XR, Zhang FQ, Qiao XY, Wang H, Li GF, Zhang YJ, Zhu Y, Cao JZ, Lan SM, Wu JX, Wu T, Zhu SY, Shi M, Xu LM, Yuan ZY, Yahalom J, Tsang R, Song YQ, Zhu J, Su H, Li YX (2020) Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK\/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making. Leukemia. https:\/\/doi.org\/10.1038\/s41375-020-0791-3","journal-title":"Leukemia"},{"key":"6243_CR34","doi-asserted-by":"publisher","unstructured":"Kim H, Jeong H, Yamaguchi M, Sohn I, Yoon SE, Byeon S, Hur JY, Koh Y, Yoon SS, Kim EJ, Oguchi M, Miyazaki K, Taguchi S, Yoon DH, Cho J, Ko YH, Kim SJ, Suzuki R, Kim WS (2020) Prediction and prevention of central nervous system relapse in patients with extranodal natural killer\/T-cell lymphoma. Blood. https:\/\/doi.org\/10.1182\/blood.2020005026","DOI":"10.1182\/blood.2020005026"},{"issue":"12","key":"6243_CR35","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.1007\/s00277-024-06071-6","volume":"103","author":"T Yang","year":"2024","unstructured":"Yang T, Sun Z, Shi Y, Teng Y, Cheng L, Zhu R, Zhang H, Wang Q, Wei J, Ding C, Tao W (2024) Development and validation of prognostic models based on 18F-FDG PET radiomics, metabolic parameters, and clinical factors for elderly DLBCL patients. Ann Hematol 103(12):5583\u20135598. https:\/\/doi.org\/10.1007\/s00277-024-06071-6","journal-title":"Ann Hematol"},{"issue":"12","key":"6243_CR36","doi-asserted-by":"publisher","first-page":"5891","DOI":"10.1007\/s00277-024-05717-9","volume":"103","author":"H Zhang","year":"2024","unstructured":"Zhang H, Xu Z, Zhou W, Chen J, Wei Y, Wu H, Wei X, Feng R (2024) Metabolic tumor volume from baseline [18F]FDG PET\/CT at diagnosis improves the IPI stratification in patients with diffuse large B-cell lymphoma. Ann Hematol 103(12):5891\u20135902. https:\/\/doi.org\/10.1007\/s00277-024-05717-9","journal-title":"Ann Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06243-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06243-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06243-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T19:40:37Z","timestamp":1743882037000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06243-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["6243"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06243-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"27 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have reviewed the final version of\u00a0the manuscript and consent to its publication in Annals of hematology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Informed consent was obtained from all subjects\u00a0involved in the study. Additionally, all participants gave their written consent for the use of their images for wound documentation in the\u00a0publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}